Atlas Trials

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Clinical trial NCT01498887 · COMPLETED

Trial details

NCT number
NCT01498887
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2011-12-24
Primary completion
2015-12-26
Enrollment
347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.